RadNet Inc
$ 63.78
1.74%
31 Jul - close price
- Market Cap 5,015,292,000 USD
- Current Price $ 63.78
- High / Low $ 64.39 / 61.49
- Stock P/E N/A
- Book Value 14.08
- EPS -0.17
- Next Earning Report 2026-08-10
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.02 %
- ROE 0.02 %
- 52 Week High 85.84
- 52 Week Low 50.76
About
RadNet, Inc., provides outpatient imaging services in the United States. The company is headquartered in Los Angeles, California.
Analyst Target Price
$89.75
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-11 | 2026-03-02 | 2025-11-09 | 2025-08-10 | 2025-05-11 | 2025-02-27 | 2024-11-10 | 2024-08-07 | 2024-05-08 | 2024-02-29 | 2023-11-08 | 2023-08-08 |
| Reported EPS | -0.28 | 0.23 | 0.2 | 0.31 | -0.35 | 0.22 | 0.18 | 0.16 | 0.07 | 0.2 | 0.14 | 0.24 |
| Estimated EPS | -0.19 | 0.2071 | 0.23 | 0.16 | -0.13 | 0.1919 | 0.17 | 0.17 | 0.01 | 0.16 | 0.07 | 0.1 |
| Surprise | -0.09 | 0.0229 | -0.03 | 0.15 | -0.22 | 0.0281 | 0.01 | -0.01 | 0.06 | 0.04 | 0.07 | 0.14 |
| Surprise Percentage | -47.3684% | 11.0575% | -13.0435% | 93.75% | -169.2308% | 14.643% | 5.8824% | -5.8824% | 600% | 25% | 100% | 140% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-10 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 0.18 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: RDNT
2026-07-31 07:40:53
RadNet's subsidiary DeepHealth received FDA clearance for its AI-powered breast ultrasound tool, which will be deployed across RadNet's network for approximately 700,000 annual studies. This move aligns with RadNet's strategy of leveraging AI for improved workflow and scalability in outpatient imaging, although near-term challenges like reimbursement pressure and AI investment needs persist. The company projects significant revenue and earnings growth by 2029, with some analysts seeing a substantial upside to its current stock price.
2026-07-30 20:10:55
DeepHealth, a subsidiary of RadNet, Inc., has received FDA 510(k) clearance for its AI-powered DeepHealth Breast Ultrasound solution. This technology aims to standardize and improve the accuracy and efficiency of breast ultrasound imaging by automating lesion detection, characterization, and reporting. The solution is now commercially available in the U.S. and will be implemented across RadNet’s network, potentially benefiting over 700,000 breast ultrasound studies annually.
2026-07-30 05:13:14
A new analysis by Definitive Healthcare identifies the 10 largest imaging center corporations in the U.S. based on location count. RadNet tops the list with approximately 383 outposts, followed by The US Oncology Network. The article notes that while the outpatient imaging market remains fragmented, corporate-backed networks are expanding through acquisitions and new site development.
2026-07-29 16:13:15
RadNet, Inc. reported a total revenue of 1.74 billion EUR last year, with its Imaging Center segment contributing the most at 1.69 billion EUR. The significant majority of this revenue, 1.71 billion EUR, was generated in the United States.
2026-07-28 15:40:50
This article provides a detailed company profile for RadNet Inc (RDNT), a national provider of diagnostic imaging services. It covers the company's business scope, including its extensive network of outpatient imaging centers and its digital health segment focusing on AI solutions for medical imaging. The article also lists key financial data, market performance indicators, and details about the company's executives and major shareholders.
2026-07-28 05:09:34
RadNet Inc (RDNT) has a strong institutional shareholding score of 10.00, placing it first in its industry. The institutional shareholding proportion has increased by 12.32% quarter-over-quarter, with Steven Cohen being the largest institutional shareholder. Several major institutional investors like BlackRock, Kaminsky, RTW Investments, and T. Rowe Price Associates hold significant stakes in the company.
